Nevertheless, since NCATS-SM7270 was nearly as effective as GSK2795039 in mouse cells and had a more favorable pharmacokinetic and specificity profile, we next tested whether this specific NOX2 inhibitor would show activity in vivo, using a mouse model of mTBI. Here, CYBB is linked to concussion.